Pathway to Diagnosis of Ovarian Cancer

Pathway to Diagnosis of Ovarian Cancer: Observational Retrospective Multicenter Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01061619

Acronym

MITO-12

Enrollment

400

Registered

2010-02-03

Start date

2010-01-31

Completion date

2024-11-30

Last updated

2023-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Keywords

prediagnostic symptoms, sentinel events, pathway to diagnosis

Brief summary

The purpose of this study is to describe the prediagnostic symptoms and the events along the pathway to diagnosis of women with ovarian cancer, referred for first-line chemotherapy.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histological diagnosis of ovarian cancer * Indication for chemotherapy * Age \> 18 years * Signed informed consent

Exclusion criteria

* Previous chemotherapy * Unable or unwilling to participate in interview

Design outcomes

Primary

Measure	Time frame
the frequency and duration of symptoms in 12 months preceding ovarian cancer diagnosis	at baseline
time intervals in weeks between prediagnostic sentinel events (onset of persistent symptoms, first physician visit, diagnosis of ovarian cancer)	at baseline
description of prediagnostic patient experiences according to modified Andersen's model of 'total patient delay'	at baseline

Countries

Belgium, Germany, Italy

Outcome results